154 related articles for article (PubMed ID: 37082056)
1. Immunohistochemical expression of putative cancer stem cell markers aldehyde dehydrogenase 1, SOX2, CD44 and OCT4 in different grades of oral epithelial dysplasia.
Thankappan P; Augustine PI; Shaga IB; Nirmal RM; Joseph TI; Girish KL
J Oral Maxillofac Pathol; 2022; 26(4):440-446. PubMed ID: 37082056
[TBL] [Abstract][Full Text] [Related]
2. Human Papilloma Virus and Cancer Stem Cell markers in Oral Epithelial Dysplasia-An Immunohistochemical Study.
Thankappan P; Ramadoss MN; Joseph TI; Augustine PI; Shaga IB; Thilak J
Rambam Maimonides Med J; 2021 Oct; 12(4):. PubMed ID: 34709167
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
5. Relative Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia.
Ghazi N; Aali N; Shahrokhi VR; Mohajertehran F; Saghravanian N
Rep Biochem Mol Biol; 2020 Jul; 9(2):171-179. PubMed ID: 33178866
[TBL] [Abstract][Full Text] [Related]
6. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Vijayakumar G; Narwal A; Kamboj M; Sen R
Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091
[TBL] [Abstract][Full Text] [Related]
7. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
8. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
Abdulmajeed AA; Dalley AJ; Farah CS
J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
[TBL] [Abstract][Full Text] [Related]
9. An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Patel NR; Jain L; Mahajan AM; Hiray PV; Shinde SS; Patel PA
Indian J Otolaryngol Head Neck Surg; 2019 Dec; 71(4):435-441. PubMed ID: 31750100
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Embryonic Cancer Stem Cells' Biomarkers SOX2 and OCT3/4 in Oral Leukoplakias and Squamous Cell Carcinomas: A Preliminary Study.
Zisis V; Andreadis D; Anastasiadou PA; Akrivou M; Vizirianakis IS; Anagnostou L; Malamos D; Paraskevopoulos K; Poulopoulos A
Cureus; 2023 Sep; 15(9):e45482. PubMed ID: 37859926
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.
Yu HH; Featherston T; Tan ST; Chibnall AM; Brasch HD; Davis PF; Itinteang T
Front Surg; 2016; 3():46. PubMed ID: 27532037
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
13. The Identification of Three Cancer Stem Cell Subpopulations within Moderately Differentiated Lip Squamous Cell Carcinoma.
Ram R; Brasch HD; Dunne JC; Davis PF; Tan ST; Itinteang T
Front Surg; 2017; 4():12. PubMed ID: 28321397
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
16. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
17. Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.
Sharada P; Swaminathan U; Nagamalini BR; Kumar KV; Ashwini BK; Lavanya V
J Oral Maxillofac Pathol; 2018; 22(1):40-47. PubMed ID: 29731555
[TBL] [Abstract][Full Text] [Related]
18. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.
Surendran S; Siddappa G; Mohan A; Hicks W; Jayaprakash V; Mimikos C; Mahri M; Almarzouki F; Morrell K; Ravi R; Govindan S; Sushma CN; Raghavan N; Birur P; Ilayaraja J; Merzianu M; Reid M; Suresh A; Kuriakose MA
Oral Oncol; 2017 Dec; 75():140-147. PubMed ID: 29224811
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
